267 related articles for article (PubMed ID: 34036938)
1. Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer.
Sacchetti A; Teeuwssen M; Verhagen M; Joosten R; Xu T; Stabile R; van der Steen B; Watson MM; Gusinac A; Kim WK; Ubink I; Van de Werken HJ; Fumagalli A; Paauwe M; Van Rheenen J; Sansom OJ; Kranenburg O; Fodde R
Elife; 2021 May; 10():. PubMed ID: 34036938
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer.
Xu T; Verhagen M; Joosten R; Sun W; Sacchetti A; Munoz Sagredo L; Orian-Rousseau V; Fodde R
Elife; 2022 Nov; 11():. PubMed ID: 36346211
[TBL] [Abstract][Full Text] [Related]
3. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
4. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
5. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
6. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
7. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
8. BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.
Zhang Y; Devocelle A; Desterke C; de Souza LEB; Hadadi É; Acloque H; Foudi A; Xiang Y; Ballesta A; Chang Y; Giron-Michel J
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065633
[TBL] [Abstract][Full Text] [Related]
9. A Positive Feed-Forward Loop between LncRNA-CYTOR and Wnt/β-Catenin Signaling Promotes Metastasis of Colon Cancer.
Yue B; Liu C; Sun H; Liu M; Song C; Cui R; Qiu S; Zhong M
Mol Ther; 2018 May; 26(5):1287-1298. PubMed ID: 29606502
[TBL] [Abstract][Full Text] [Related]
10. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
11. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer.
Xu T; Verhagen MP; Teeuwssen M; Sun W; Joosten R; Sacchetti A; Ewing-Graham PC; Jansen MPHM; Boere IA; Bryce NS; Zeng J; Treutlein HR; Hook J; Hardeman EC; Gunning PW; Fodde R
Cell Death Differ; 2024 Mar; 31(3):360-377. PubMed ID: 38365970
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Tang X; Zha L; Li H; Liao G; Huang Z; Peng X; Wang Z
Oncol Rep; 2017 Oct; 38(4):2023-2032. PubMed ID: 28849076
[TBL] [Abstract][Full Text] [Related]
13. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration.
Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
[TBL] [Abstract][Full Text] [Related]
14. Substrate Stiffness Drives Epithelial to Mesenchymal Transition and Proliferation through the
Xu X; Zhang Y; Wang X; Li S; Tang L
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769497
[TBL] [Abstract][Full Text] [Related]
15. ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway.
Du J; Zhu Z; Xu L; Chen X; Li X; Lan T; Li W; Yuan K; Zeng Y
Aging (Albany NY); 2020 Oct; 12(20):20235-20253. PubMed ID: 33122451
[TBL] [Abstract][Full Text] [Related]
16. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
[TBL] [Abstract][Full Text] [Related]
17. β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers.
Kim WK; Kwon Y; Jang M; Park M; Kim J; Cho S; Jang DG; Lee WB; Jung SH; Choi HJ; Min BS; Il Kim T; Hong SP; Paik YK; Kim H
Sci Rep; 2019 Dec; 9(1):18440. PubMed ID: 31804558
[TBL] [Abstract][Full Text] [Related]
18. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
[TBL] [Abstract][Full Text] [Related]
19. Identification of TRPV4 as a novel target in invasiveness of colorectal cancer.
Zhang P; Xu J; Zhang H; Liu XY
BMC Cancer; 2021 Nov; 21(1):1264. PubMed ID: 34814869
[TBL] [Abstract][Full Text] [Related]
20. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]